Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

ImmuCell Q2 EPS $0.06 Up From $(0.20) YoY, Sales $6.445M Up From $5.473M YoY

Author: Benzinga Newsdesk | August 14, 2025 04:06pm
ImmuCell (NASDAQ:ICCC) reported quarterly earnings of $0.06 per share. This is a 130 percent increase over losses of $(0.20) per share from the same period last year. The company reported $6.445 million in sales this quarter. This is a 17.76 percent increase over sales of $5.473 million the same period last year.

Posted In: ICCC


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist